A detailed history of Algert Global LLC transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Algert Global LLC holds 27,399 shares of AVIR stock, worth $87,402. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,399
Previous 24,297 12.77%
Holding current value
$87,402
Previous $80,000 15.0%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$3.17 - $4.02 $9,833 - $12,470
3,102 Added 12.77%
27,399 $92,000
Q2 2024

Aug 14, 2024

BUY
$3.31 - $4.04 $4,094 - $4,997
1,237 Added 5.36%
24,297 $80,000
Q1 2024

May 14, 2024

SELL
$3.09 - $4.56 $42,765 - $63,110
-13,840 Reduced 37.51%
23,060 $93,000
Q4 2023

Feb 14, 2024

SELL
$2.8 - $3.35 $38,108 - $45,593
-13,610 Reduced 26.95%
36,900 $113,000
Q3 2023

Nov 13, 2023

BUY
$3.0 - $3.79 $6,690 - $8,451
2,230 Added 4.62%
50,510 $152,000
Q2 2023

Aug 14, 2023

BUY
$3.21 - $5.06 $77,165 - $121,637
24,039 Added 99.17%
48,280 $181,000
Q1 2023

May 12, 2023

BUY
$3.0 - $4.97 $7,851 - $13,006
2,617 Added 12.1%
24,241 $81,000
Q3 2022

Nov 15, 2022

SELL
$5.49 - $8.79 $21,037 - $33,683
-3,832 Reduced 15.05%
21,624 $123,000
Q2 2022

Aug 15, 2022

BUY
$5.33 - $8.18 $135,680 - $208,230
25,456 New
25,456 $181,000

Others Institutions Holding AVIR

About Atea Pharmaceuticals, Inc.


  • Ticker AVIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,258,600
  • Market Cap $266M
  • Description
  • Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...
More about AVIR
Track This Portfolio

Track Algert Global LLC Portfolio

Follow Algert Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.